1. Home
  2. SMWB vs MYGN Comparison

SMWB vs MYGN Comparison

Compare SMWB & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$7.17

Market Cap

551.0M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.32

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMWB
MYGN
Founded
2007
1991
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
551.0M
444.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
SMWB
MYGN
Price
$7.17
$5.32
Analyst Decision
Hold
Buy
Analyst Count
6
7
Target Price
$4.00
$7.64
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$11.07
$6.86
Revenue Next Year
$11.17
$5.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$2.22
$3.53
52 Week High
$10.75
$8.59

Technical Indicators

Market Signals
Indicator
SMWB
MYGN
Relative Strength Index (RSI) 63.64 43.33
Support Level $6.91 $4.24
Resistance Level $7.84 $5.52
Average True Range (ATR) 0.53 0.29
MACD -0.08 -0.13
Stochastic Oscillator 76.91 6.25

Price Performance

Historical Comparison
SMWB
MYGN

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: